カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

がん治療薬の世界市場2022：化学療法、標的療法、免疫療法、ホルモン療法、その他

◆英語タイトル：Global Oncology Therapeutic Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22NO19472）◆商品コード：GIR22NO19472
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年11月（※2025年版があります。お問い合わせください。）
◆ページ数：123
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

がん治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のがん治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

がん治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・化学療法、標的療法、免疫療法、ホルモン療法、その他

用途別セグメントは次のように区分されます。
・乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他

世界のがん治療薬市場の主要な市場プレーヤーは以下のとおりです。
・AbbVie、Amgen、Astellas Pharma、AstraZeneca、Bayer、Biogen、Bristol Myers Squibb、Celgene、Eisai、Eli Lilly and Company、Gilead Sciences、Ipsen、Johnson and Johnson、Merck、Novartis、Otsuka Pharmaceutical、Pfizer、F. Hoffmann-La Roche、Sanofi、Takeda Pharmaceutical、Teva Pharmaceutical Industries

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、がん治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要ながん治療薬メーカーの企業概要、2019年～2022年までのがん治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要ながん治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別がん治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのがん治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのがん治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびがん治療薬の産業チェーンを掲載しています。
・第13、14、15章では、がん治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- がん治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：化学療法、標的療法、免疫療法、ホルモン療法、その他
- 用途別分析（2017年vs2021年vs2028年）：乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他
- 世界のがん治療薬市場規模・予測
- 世界のがん治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- AbbVie、Amgen、Astellas Pharma、AstraZeneca、Bayer、Biogen、Bristol Myers Squibb、Celgene、Eisai、Eli Lilly and Company、Gilead Sciences、Ipsen、Johnson and Johnson、Merck、Novartis、Otsuka Pharmaceutical、Pfizer、F. Hoffmann-La Roche、Sanofi、Takeda Pharmaceutical、Teva Pharmaceutical Industries
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：化学療法、標的療法、免疫療法、ホルモン療法、その他
・用途別分析2017年-2028年：乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他
・がん治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・がん治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・がん治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・がん治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・がん治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oncology Therapeutic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oncology Therapeutic Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Breast Cancer accounting for % of the Oncology Therapeutic Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemotherapy segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oncology Therapeutic Drug include AbbVie, Amgen, Astellas Pharma, AstraZeneca, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology Therapeutic Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
Market segment by Application can be divided into
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory and Lung Cancer
Others
The key market players for global Oncology Therapeutic Drug market are listed below:
AbbVie
Amgen
Astellas Pharma
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Celgene
Eisai
Eli Lilly and Company
Gilead Sciences
Ipsen
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
F. Hoffmann-La Roche
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Therapeutic Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology Therapeutic Drug, with price, sales, revenue and global market share of Oncology Therapeutic Drug from 2019 to 2022.
Chapter 3, the Oncology Therapeutic Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Therapeutic Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oncology Therapeutic Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Therapeutic Drug.
Chapter 13, 14, and 15, to describe Oncology Therapeutic Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Oncology Therapeutic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Therapeutic Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Therapeutic Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory and Lung Cancer
1.3.6 Others
1.4 Global Oncology Therapeutic Drug Market Size & Forecast
1.4.1 Global Oncology Therapeutic Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oncology Therapeutic Drug Sales in Volume (2017-2028)
1.4.3 Global Oncology Therapeutic Drug Price (2017-2028)
1.5 Global Oncology Therapeutic Drug Production Capacity Analysis
1.5.1 Global Oncology Therapeutic Drug Total Production Capacity (2017-2028)
1.5.2 Global Oncology Therapeutic Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Therapeutic Drug Market Drivers
1.6.2 Oncology Therapeutic Drug Market Restraints
1.6.3 Oncology Therapeutic Drug Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Oncology Therapeutic Drug Product and Services
2.1.4 AbbVie Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Oncology Therapeutic Drug Product and Services
2.2.4 Amgen Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business
2.3.3 Astellas Pharma Oncology Therapeutic Drug Product and Services
2.3.4 Astellas Pharma Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Oncology Therapeutic Drug Product and Services
2.4.4 AstraZeneca Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Oncology Therapeutic Drug Product and Services
2.5.4 Bayer Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business
2.6.3 Biogen Oncology Therapeutic Drug Product and Services
2.6.4 Biogen Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bristol Myers Squibb
2.7.1 Bristol Myers Squibb Details
2.7.2 Bristol Myers Squibb Major Business
2.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Product and Services
2.7.4 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Celgene
2.8.1 Celgene Details
2.8.2 Celgene Major Business
2.8.3 Celgene Oncology Therapeutic Drug Product and Services
2.8.4 Celgene Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Oncology Therapeutic Drug Product and Services
2.9.4 Eisai Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business
2.10.3 Eli Lilly and Company Oncology Therapeutic Drug Product and Services
2.10.4 Eli Lilly and Company Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Gilead Sciences
2.11.1 Gilead Sciences Details
2.11.2 Gilead Sciences Major Business
2.11.3 Gilead Sciences Oncology Therapeutic Drug Product and Services
2.11.4 Gilead Sciences Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Ipsen
2.12.1 Ipsen Details
2.12.2 Ipsen Major Business
2.12.3 Ipsen Oncology Therapeutic Drug Product and Services
2.12.4 Ipsen Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Johnson and Johnson
2.13.1 Johnson and Johnson Details
2.13.2 Johnson and Johnson Major Business
2.13.3 Johnson and Johnson Oncology Therapeutic Drug Product and Services
2.13.4 Johnson and Johnson Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Merck
2.14.1 Merck Details
2.14.2 Merck Major Business
2.14.3 Merck Oncology Therapeutic Drug Product and Services
2.14.4 Merck Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Oncology Therapeutic Drug Product and Services
2.15.4 Novartis Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Otsuka Pharmaceutical
2.16.1 Otsuka Pharmaceutical Details
2.16.2 Otsuka Pharmaceutical Major Business
2.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Product and Services
2.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Pfizer
2.17.1 Pfizer Details
2.17.2 Pfizer Major Business
2.17.3 Pfizer Oncology Therapeutic Drug Product and Services
2.17.4 Pfizer Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 F. Hoffmann-La Roche
2.18.1 F. Hoffmann-La Roche Details
2.18.2 F. Hoffmann-La Roche Major Business
2.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Product and Services
2.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Sanofi
2.19.1 Sanofi Details
2.19.2 Sanofi Major Business
2.19.3 Sanofi Oncology Therapeutic Drug Product and Services
2.19.4 Sanofi Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Takeda Pharmaceutical
2.20.1 Takeda Pharmaceutical Details
2.20.2 Takeda Pharmaceutical Major Business
2.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Product and Services
2.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Teva Pharmaceutical Industries
2.21.1 Teva Pharmaceutical Industries Details
2.21.2 Teva Pharmaceutical Industries Major Business
2.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product and Services
2.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oncology Therapeutic Drug Breakdown Data by Manufacturer
3.1 Global Oncology Therapeutic Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oncology Therapeutic Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oncology Therapeutic Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology Therapeutic Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Oncology Therapeutic Drug Manufacturer Market Share in 2021
3.5 Global Oncology Therapeutic Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oncology Therapeutic Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology Therapeutic Drug Market Size by Region
4.1.1 Global Oncology Therapeutic Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Oncology Therapeutic Drug Revenue by Region (2017-2028)
4.2 North America Oncology Therapeutic Drug Revenue (2017-2028)
4.3 Europe Oncology Therapeutic Drug Revenue (2017-2028)
4.4 Asia-Pacific Oncology Therapeutic Drug Revenue (2017-2028)
4.5 South America Oncology Therapeutic Drug Revenue (2017-2028)
4.6 Middle East and Africa Oncology Therapeutic Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oncology Therapeutic Drug Sales in Volume by Type (2017-2028)
5.2 Global Oncology Therapeutic Drug Revenue by Type (2017-2028)
5.3 Global Oncology Therapeutic Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oncology Therapeutic Drug Sales in Volume by Application (2017-2028)
6.2 Global Oncology Therapeutic Drug Revenue by Application (2017-2028)
6.3 Global Oncology Therapeutic Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oncology Therapeutic Drug Sales by Type (2017-2028)
7.2 North America Oncology Therapeutic Drug Sales by Application (2017-2028)
7.3 North America Oncology Therapeutic Drug Market Size by Country
7.3.1 North America Oncology Therapeutic Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Oncology Therapeutic Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology Therapeutic Drug Sales by Type (2017-2028)
8.2 Europe Oncology Therapeutic Drug Sales by Application (2017-2028)
8.3 Europe Oncology Therapeutic Drug Market Size by Country
8.3.1 Europe Oncology Therapeutic Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Oncology Therapeutic Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oncology Therapeutic Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Oncology Therapeutic Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Oncology Therapeutic Drug Market Size by Region
9.3.1 Asia-Pacific Oncology Therapeutic Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oncology Therapeutic Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oncology Therapeutic Drug Sales by Type (2017-2028)
10.2 South America Oncology Therapeutic Drug Sales by Application (2017-2028)
10.3 South America Oncology Therapeutic Drug Market Size by Country
10.3.1 South America Oncology Therapeutic Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Oncology Therapeutic Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology Therapeutic Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Oncology Therapeutic Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Oncology Therapeutic Drug Market Size by Country
11.3.1 Middle East & Africa Oncology Therapeutic Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oncology Therapeutic Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oncology Therapeutic Drug
12.3 Oncology Therapeutic Drug Production Process
12.4 Oncology Therapeutic Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oncology Therapeutic Drug Typical Distributors
13.3 Oncology Therapeutic Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ がん治療薬の世界市場2022：化学療法、標的療法、免疫療法、ホルモン療法、その他(Global Oncology Therapeutic Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ゾリンジャーエリソン症候群治療のグローバル市場展望 2023年-2029年：化学療法、外科的切除、その他
  • 勃起不全用経口治療薬の世界市場2022：タンパク質、ホルモン、その他
  • 卵巣がん治療薬の世界市場2022：手術用、化学療法、放射線、生物療法
  • 卵巣がん治療薬の世界市場2022：手術用、化学療法、放射線、生物療法
  • 喘息治療薬の世界市場2022：長期管理薬、速効薬